Larvol Delta - atai-Life-Sciences-Announces-First-Patient-Dosed-in-Elumina-the-Phase-2-Clinical-Trial-of-VLS01-for-TreatmentResistant-Depression

N,N-dimethyltryptamine (VLS-01) - atai Life Sci

https://www.globenewswire.com/news-release/2025/03/11/3040405/0/en/atai-Life-Sciences-Announces-First-Patient-Dosed-in-Elumina-the-Phase-2-Clinical-Trial-of-VLS-01-for-Treatment-Resistant-Depression.html

Mar 11, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next